Rapid Update 3- June 2017: Biosimilars: NOR-SWITCH study provides evidence to support switching from originator to biosimilar infliximab in stable patients

This content is available to authorised users working in organisations that subscribe to ScriptSwitch only. Authorised users need to be logged in to read this content.

Healthcare professionals working in organisations that subscribe to ScriptSwitch may register to request access – please submit your details via the ‘register’ link at the top of this page.

Rapid Update 3 – October 2016: Bioequivalence of biosimilar tumour necrosis factor (TNF)-alpha inhibitors compared with their reference biologics: A systematic review

This content is available to authorised users working in organisations that subscribe to ScriptSwitch only. Authorised users need to be logged in to read this content.

Healthcare professionals working in organisations that subscribe to ScriptSwitch may register to request access – please submit your details via the ‘register’ link at the top of this page.